IS7065A - Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð - Google Patents

Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð

Info

Publication number: IS7065A
Authority: IS; Iceland
Prior art keywords: medication regimen; dose medication; emergency contraceptive; contraceptive formulations; formulations
Prior art date: 2001-11-27

Application number

IS7065A

Other languages

English (en)

Other versions

IS2691B (is

Inventor

F. A. Van Look Paul

Szabo Zsolt

Balogh Illesne

Komandi Katalin

βszlo Nemes L

Original Assignee

Richter Gedeon Vegyészeti Gy βr Rt.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-27

Filing date

2003-12-05

Publication date

2003-12-05

2003-12-05 Application filed by Richter Gedeon Vegyészeti Gy βr Rt. filed Critical Richter Gedeon Vegyészeti Gy βr Rt.

2003-12-05 Publication of IS7065A publication Critical patent/IS7065A/is

2010-10-15 Publication of IS2691B publication Critical patent/IS2691B/is

Links

239000003433 contraceptive agent Substances 0.000 title 1
230000002254 contraceptive effect Effects 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

IS7065A 2001-11-27 2003-12-05 Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð IS2691B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0105173A HU227198B1 (en)	2001-11-27	2001-11-27	Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en)	2001-11-27	2002-11-26	Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number	Publication Date
IS7065A true IS7065A (is)	2003-12-05
IS2691B IS2691B (is)	2010-10-15

Family

ID=89998939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7065A IS2691B (is)	2001-11-27	2003-12-05	Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð

Country Status (33)

Country	Link
US (1)	US20050288264A2 (is)
EP (1)	EP1448207B1 (is)
JP (1)	JP2005516904A (is)
KR (1)	KR100908161B1 (is)
CN (1)	CN1551774A (is)
AP (1)	AP1849A (is)
AT (1)	ATE293978T1 (is)
AU (1)	AU2002347401A1 (is)
BR (1)	BR0210595A (is)
CA (1)	CA2450359C (is)
DE (1)	DE60203929T2 (is)
DK (1)	DK1448207T3 (is)
EA (1)	EA006545B1 (is)
EC (1)	ECSP045171A (is)
ES (1)	ES2239727T3 (is)
GE (1)	GEP20063882B (is)
HR (1)	HRP20040584B1 (is)
HU (1)	HU227198B1 (is)
IL (1)	IL159394A0 (is)
IS (1)	IS2691B (is)
MA (1)	MA27076A1 (is)
MX (1)	MXPA04005104A (is)
NO (1)	NO333984B1 (is)
NZ (1)	NZ530056A (is)
OA (1)	OA12730A (is)
PL (1)	PL206010B1 (is)
PT (1)	PT1448207E (is)
RS (1)	RS50768B (is)
SI (1)	SI1448207T1 (is)
TN (1)	TNSN04048A1 (is)
UA (1)	UA79942C2 (is)
WO (1)	WO2003045397A1 (is)
ZA (1)	ZA200404114B (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2465907C2 (ru) *	2006-12-20	2012-11-10	Тева Вимен'С Хелс, Инк.	Распадающиеся в полости рта твердые дозированные формы, содержащие прогестин, и способы получения и применение указанных дозированных форм
US20090170823A1 (en) *	2007-12-20	2009-07-02	Duramed Pharmaceuticals, Inc.	Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
US8512745B2 (en)	2008-12-08	2013-08-20	Laboratoire Hra Pharma	Ulipristal acetate tablets
EP2365811A1 (en) *	2008-12-12	2011-09-21	Laboratoire HRA Pharma	A method for contraception
WO2010119029A1 (en)	2009-04-14	2010-10-21	Laboratoire Hra-Pharma	Method for on-demand contraception
CN102458386B (zh)	2009-06-23	2016-04-06	拜耳知识产权有限责任公司	用于紧急避孕的药物组合物
CN101732324B (zh) *	2009-12-31	2011-12-07	广州朗圣药业有限公司	一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
RS54880B1 (sr)	2011-06-01	2016-10-31	Estetra Sprl	Postupak proizvodnje intermedijarnih proizvoda estetrola
ME02585B (me)	2011-06-01	2017-06-20	Estetra Sprl	Postupak proizvodnje intermedijara estetrola
EP2383279A1 (en)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Process for the preparation of estetrol
CA2843951C (en) *	2011-08-11	2019-08-06	Wout WOUTERS	Use of estetrol as emergency contraceptive
SG11201503275RA (en)	2012-11-22	2015-06-29	Bayer Pharma AG	Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
CN105451737B (zh)	2013-05-23	2018-04-10	拜耳医药股份有限公司	药物组合物及其用途以及所述药物组合物用于按需避孕的施用方法
CN103877058A (zh) *	2014-03-26	2014-06-25	邵娜	一种左炔诺孕酮片及其制备工艺
EP3701944B1 (en)	2015-06-18	2021-12-08	Estetra SRL	Orodispersible dosage unit containing an estetrol component
MA44206B1 (fr)	2015-06-18	2021-04-30	Estetra Sprl	Comprimé orodispersible comprenant estetrol
CU24523B1 (es)	2015-06-18	2021-06-08	Estetra Sprl	Unidad de dosificación orodispersable que contiene un componente estetrol
LT3310345T (lt)	2015-06-18	2021-06-25	Estetra Sprl	Burnoje disperguojama tabletė, turinti estetrolio
CA3178291A1 (en)	2016-08-05	2018-04-12	Estetra Srl	Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en)	2018-04-19	2022-02-09	Estetra SRL	Compounds and their uses for alleviating menopause-associated symptoms
CN110917154A (zh) *	2019-12-12	2020-03-27	上海信谊天平药业有限公司	一种左炔诺孕酮片的制备方法
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
WO2022026901A2 (en) *	2020-07-30	2022-02-03	Acer Therapeutics Inc.	Nk antagonists for contraception
CN119523923A (zh) *	2024-11-21	2025-02-28	华中药业股份有限公司	一种左炔诺孕酮片及其制备方法

2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
2002
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 EP EP02783334A patent/EP1448207B1/en not_active Expired - Lifetime
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/en not_active Ceased
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko not_active Expired - Lifetime
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 CA CA2450359A patent/CA2450359C/en not_active Expired - Lifetime
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned

Also Published As

Publication number	Publication date
TNSN04048A1 (en)	2006-06-01
KR100908161B1 (ko)	2009-07-16
EA200400731A1 (ru)	2004-12-30
WO2003045397A1 (en)	2003-06-05
CA2450359C (en)	2011-05-10
JP2005516904A (ja)	2005-06-09
ECSP045171A (es)	2004-08-27
AP2004003046A0 (en)	2004-06-30
ATE293978T1 (de)	2005-05-15
EP1448207B1 (en)	2005-04-27
ZA200404114B (en)	2005-10-26
HU227198B1 (en)	2010-10-28
MA27076A1 (fr)	2004-12-20
EP1448207A1 (en)	2004-08-25
NZ530056A (en)	2005-02-25
PL369520A1 (en)	2005-04-18
BR0210595A (pt)	2004-06-08
RS4204A (sr)	2007-02-05
OA12730A (fr)	2006-06-28
DK1448207T3 (da)	2005-06-27
SI1448207T1 (en)	2005-10-31
PL206010B1 (pl)	2010-06-30
UA79942C2 (en)	2007-08-10
NO333984B1 (no)	2013-11-04
US20050288264A2 (en)	2005-12-29
HUP0105173D0 (en)	2002-02-28
EA006545B1 (ru)	2006-02-24
MXPA04005104A (es)	2004-08-19
HRP20040584A2 (en)	2005-02-28
KR20040066088A (ko)	2004-07-23
DE60203929D1 (de)	2005-06-02
NO20041607L (no)	2004-04-20
IL159394A0 (en)	2004-06-01
HRP20040584B1 (en)	2012-11-30
RS50768B (sr)	2010-08-31
AU2002347401A1 (en)	2003-06-10
DE60203929T2 (de)	2006-01-19
AP1849A (en)	2008-05-23
HUP0105173A2 (hu)	2003-08-28
GEP20063882B (en)	2006-07-25
US20050032755A1 (en)	2005-02-10
HUP0105173A3 (en)	2004-03-29
CN1551774A (zh)	2004-12-01
CA2450359A1 (en)	2003-06-05
IS2691B (is)	2010-10-15
PT1448207E (pt)	2005-08-31
ES2239727T3 (es)	2005-10-01

Publication	Publication Date	Title
IS2691B (is)	2010-10-15	Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð
NO20043904L (no)	2004-11-11	Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
IS6892A (is)	2003-07-24	Lyfjasamsetningar, skammtaform og aðferðir til aðgefa epóþílon um munn
IS7076A (is)	2003-12-15	Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
ATE317260T1 (de)	2006-02-15	Pharmazeutische formulierungen mit platinderivaten
ITMI20011401A0 (it)	2001-07-02	Formulazioni farmaceutiche per ormoni tiroidei
EP1513825A4 (en)	2011-01-05	ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
BRPI0209720A2 (pt)	2017-06-13	dosagem e embalagem de medicação com liberação controlada
ATE320807T1 (de)	2006-04-15	Pharmazeutische zusammensetzungen enthaltend tegaserod
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
DK1210119T3 (da)	2005-06-20	Farmaceutiske sammensætninger til oral og topisk administrering
IS7266A (is)	2004-05-14	Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
NO20043333L (no)	2004-09-13	Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE507831T1 (de)	2011-05-15	Melatonin enthaltende pharmazeutische formulierung
DE60328119D1 (de)	2009-08-06	Pharmazeutische zubereitungen enthaltend modafinil
NO20026055L (no)	2003-02-24	Farmasöytiske komponenter innbefattende humant paratyreoideahormon og farmasöytiske sammenstninger for nasal administrering inneholdendekomponentene
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
DE60217369D1 (de)	2007-02-15	Pharmazeutische zusammensetzung enthaltend gamma-butyrobetain
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
DK1406591T3 (da)	2007-06-25	Farmaceutisk sammensætning til nasal tilförsel af estradiol og norethisteron
NO20041236L (no)	2004-03-24	Farmasoytisk formulering